| Bioactivity | Mito-SilylDCA is a pyruvatedehy drogenase kinase inhibitor, which contains the TPP moiety to target PDK1 in the mitochondrial network, multiple DCA moieties for PDK1inhibition, the polyethylene long chain， and the silyl group[1]. |
| Name | Mito-SilylDCA |
| Formula | C52H77BrCl4NO6PSi |
| Molar Mass | 1092.95 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Xiao Zhang, et.al. All-in-One Pyruvate Dehydrogenase Kinase Inhibitor for Tracking, Targeting, and Enhanced Efficacy. Bioconjugate Chemistry. 2023 34 (6), 1122-1129 |
Mito-SilylDCA
CAS: F: C52H77BrCl4NO6PSi W: 1092.95
Mito-SilylDCA is a pyruvatedehy drogenase kinase inhibitor, which contains the TPP moiety to target PDK1 in the mitochon
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.